Last updated: 20 July 2019 at 5:50am EST

Howard Benjamin Net Worth




The estimated Net Worth of Howard Benjamin is at least $10.1 Million dollars as of 14 December 2017. Howard Benjamin owns over 12,729 units of Repligen stock worth over $6,687,746 and over the last 16 years Howard sold RGEN stock worth over $3,447,885.

Howard Benjamin RGEN stock SEC Form 4 insiders trading

Howard has made over 12 trades of the Repligen stock since 2013, according to the Form 4 filled with the SEC. Most recently Howard exercised 12,729 units of RGEN stock worth $305,623 on 14 December 2017.

The largest trade Howard's ever made was exercising 102,036 units of Repligen stock on 5 June 2014 worth over $448,958. On average, Howard trades about 16,466 units every 94 days since 2009. As of 14 December 2017 Howard still owns at least 46,637 units of Repligen stock.

You can see the complete history of Howard Benjamin stock trades at the bottom of the page.



What's Howard Benjamin's mailing address?

Howard's mailing address filed with the SEC is C/O REPLIGEN CORPORATION, 41 SEYON STREET, WALTHAM, MA, 02453.

Insiders trading at Repligen

Over the last 21 years, insiders at Repligen have traded over $118,224,292 worth of Repligen stock and bought 160,440 units worth $1,459,521 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Glenn P Muir, and Walter C Herlihy. On average, Repligen executives and independent directors trade stock every 33 days with the average trade being worth of $3,015,702. The most recent stock trade was executed by Ralf Kuriyel on 2 August 2024, trading 7,148 units of RGEN stock currently worth $1,139,034.



What does Repligen do?

repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.



What does Repligen's logo look like?

Repligen Corp. logo

Complete history of Howard Benjamin stock trades at Repligen

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
14 Dec 2017 Howard Benjamin
Option 12,729 $24.01 $305,623
14 Dec 2017
46,637
20 Mar 2017 Howard Benjamin
Option 14,968 $9.44 $141,298
20 Mar 2017
33,908
24 May 2016 Howard Benjamin
Option 10,000 $6.23 $62,300
24 May 2016
28,626
11 May 2016 Howard Benjamin
Sale 2,889 $26.72 $77,194
11 May 2016
18,626
19 Nov 2015 Howard Benjamin
Option 5,000 $3.33 $16,650
19 Nov 2015
16,554
19 Nov 2015 Howard Benjamin
Option 5,000 $3.33 $16,650
19 Nov 2015
16,554
8 Jun 2015 Howard Benjamin
Sale 35,000 $38.14 $1,334,900
8 Jun 2015
11,554
19 Mar 2015 Howard Benjamin
Sale 15,795 $32.63 $515,391
19 Mar 2015
46,554
11 Nov 2014 Howard Benjamin
Sale 30,000 $23.56 $706,800
11 Nov 2014
43,851
13 Aug 2014 Howard Benjamin
Sale 40,000 $20.34 $813,600
13 Aug 2014
73,851
5 Jun 2014 Howard Benjamin
Option 102,036 $4.40 $448,958
5 Jun 2014
111,920
6 May 2013 Howard Benjamin
Option 22,964 $3.85 $88,411
6 May 2013
26,731


Repligen executives and stock owners

Repligen executives and other stock owners filed with the SEC include: